Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33151260.
- Also identified by DOI 10.1001/jamaoncol.2020.5745 and PMC identifier 7645735.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the implementation of a microbiologic screening pilot program in Al Zahra Hospital in the United Arab Emirates for identifying presymptomatic COVID-19 in patients with cancer.
Medical subject headings
- Antineoplastic Agents
- COVID-19
- Neoplasms